|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115,400.00 KRW | -2.78% |
|
+0.26% | +67.73% |
| Nov. 14 | Yuhan Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 | CI |
| Oct. 29 | Yuhan's Net Income, Sales Climb in Q3 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 8,642B 6.18B 5.86B 5.45B 4.87B 8.66B 523B 9.49B 67.49B 25.13B 214B 23.22B 22.71B 930B | P/E ratio 2024 * |
66.5x | P/E ratio 2025 * | 47.2x |
|---|---|---|---|---|---|
| Enterprise value | 8.54B 6.11M 5.79M 5.39M 4.81M 8.56M 517M 9.38M 66.69M 24.83M 212M 22.95M 22.44M 919M | EV / Sales 2024 * |
4.07x | EV / Sales 2025 * | 3.69x |
| Free-Float |
67.64% | Yield 2024 * |
0.37% | Yield 2025 * | 0.37% |
More valuation ratios
* Estimated data
More news
| 1 day | -2.78% | ||
| 1 week | +0.26% | ||
| 1 month | -16.80% | ||
| 3 months | -18.16% | ||
| 6 months | +67.73% | ||
| Current year | +67.73% |
1 week
113 100.00
121 400.00
1 month
113 100.00142 400.00
Current year
57 500.00166 900.00
1 year
57 142.86166 900.00
3 years
47 571.43166 900.00
5 years
30 851.34166 900.00
10 years
21 997.28166 900.00
| Director | Title | Age | Since |
|---|---|---|---|
Wuk-Jae Cho
CEO | Chief Executive Officer | 69 | 2021-03-18 |
Yeol-Hong Kim
CTO | Chief Tech/Sci/R&D Officer | 65 | 2023-02-28 |
Byeong-Man Lee
PRN | Corporate Officer/Principal | 66 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeong-Hui Lee
CHM | Chairman | 73 | 2021-03-18 |
Wuk-Jae Cho
BRD | Director/Board Member | 69 | 2015-03-19 |
Byeong-Man Lee
BRD | Director/Board Member | 66 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.53% | 2 M€ | -14.14% | ||
| 0.10% | 12 M€ | +8.04% | ||
| 0.09% | 28 M€ | +6.48% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -2.78% | +0.26% | +97.67% | +131.12% | 6.18B | ||
| +0.46% | -0.11% | -11.58% | -35.31% | 64.96B | ||
| -0.72% | -1.47% | +2.01% | -21.58% | 8.41B | ||
| -0.56% | -1.63% | +24.84% | +46.59% | 6.13B | ||
| +0.39% | +8.39% | +20.09% | +8.50% | 5.79B | ||
| +5.05% | +12.14% | -2.88% | -33.50% | 3.2B | ||
| +1.50% | +0.66% | +17.12% | +25.44% | 2.26B | ||
| -1.14% | +0.97% | +34.20% | +22.02% | 2.02B | ||
| +2.67% | +3.29% | -24.35% | +34.13% | 2.01B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| Average | +0.49% | +1.37% | +17.46% | +19.71% | 10.26B | |
| Weighted average by Cap. | +0.27% | +0.15% | +1.85% | -12.55% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 2,096B 1.5B 1.42B 1.32B 1.18B 2.1B 127B 2.3B 16.37B 6.1B 52.02B 5.63B 5.51B 226B | 2,283B 1.63B 1.55B 1.44B 1.29B 2.29B 138B 2.51B 17.83B 6.64B 56.67B 6.14B 6B 246B |
| Net income | 136B 97.29M 92.21M 85.79M 76.58M 136M 8.23B 149M 1.06B 396M 3.38B 366M 357M 14.64B | 195B 140M 132M 123M 110M 195M 11.8B 214M 1.52B 567M 4.84B 524M 512M 21B |
| Net Debt | -102B -72.96M -69.15M -64.34M -57.43M -102M -6.17B -112M -797M -297M -2.53B -274M -268M -10.98B | -212B -152M -144M -134M -119M -212M -12.82B -233M -1.66B -616M -5.26B -570M -557M -22.82B |
More financial data
* Estimated data
Employees
1,999
Sector
Pharmaceuticals
Calendar
2025-04-06
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-11-29 | 115,400.00 ₩ | -2.78% | 977,409 |
| 24-11-28 | 118,700.00 ₩ | +2.06% | 1,694,657 |
| 24-11-27 | 116,300.00 ₩ | +2.11% | 1,200,590 |
| 24-11-26 | 113,900.00 ₩ | -3.64% | 1,514,521 |
| 24-11-25 | 118,200.00 ₩ | +2.69% | 2,236,522 |
End-of-day quote Korea S.E., November 28, 2024
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
115,400.00KRW
Average target price
128,812.50KRW
Spread / Average Target
+11.62%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A000100 Stock